At a glance
- Originator Eisai Co Ltd
- Class
- Mechanism of Action 5-HT1A serotonin receptor antagonists; Serotonin 5-HT2 receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Muscle spasticity
Most Recent Events
- 17 Apr 2000 Phase-I clinical trials for Spasticity in Japan (Unknown route)